The FDA has approved the following drugs in April and May:

• Taclonex Scalp Suspension (calcipotriene; betamethasone diproprionate) details
• A variety of cetirizine products from various vendors continues to enter the marketplace.
• Patanase nasal spray (olapatadine) detail
• Treximet (sumatriptan/naproxen sodium) detail
• Aplenzin (buproprion hydrobromide) detail